NO20005724L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005724L
NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
NO20005724A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005724D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005724D0 publication Critical patent/NO20005724D0/no
Publication of NO20005724L publication Critical patent/NO20005724L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005724A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005724D0 NO20005724D0 (no) 2000-11-13
NO20005724L true NO20005724L (no) 2001-01-09

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
US (1) US6537576B1 (de)
EP (1) EP1082102B1 (de)
JP (1) JP2002514587A (de)
KR (1) KR100592971B1 (de)
CN (1) CN1309553A (de)
AT (1) ATE310500T1 (de)
AU (1) AU736480B2 (de)
CA (1) CA2331527C (de)
DE (2) DE69928524T2 (de)
ES (1) ES2155048T3 (de)
GR (1) GR20010300013T1 (de)
HU (1) HUP0102426A2 (de)
IL (2) IL139576A0 (de)
NO (1) NO20005724L (de)
NZ (1) NZ508073A (de)
PL (1) PL344051A1 (de)
SE (1) SE9801704D0 (de)
TR (1) TR200003589T2 (de)
WO (1) WO1999058108A1 (de)
ZA (1) ZA200006474B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
AU2007260739A1 (en) 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
AU2009302853B2 (en) 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ, インク.Dermira, Inc. グリコピロレート塩
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
IL139576A (en) 2007-07-04
HUP0102426A2 (hu) 2002-03-28
ATE310500T1 (de) 2005-12-15
CN1309553A (zh) 2001-08-22
SE9801704D0 (sv) 1998-05-14
NZ508073A (en) 2002-12-20
WO1999058108A1 (en) 1999-11-18
DE69928524D1 (de) 2005-12-29
TR200003589T2 (tr) 2001-03-21
EP1082102B1 (de) 2005-11-23
KR100592971B1 (ko) 2006-06-23
NO20005724D0 (no) 2000-11-13
CA2331527A1 (en) 1999-11-18
JP2002514587A (ja) 2002-05-21
ES2155048T3 (es) 2006-06-16
GR20010300013T1 (en) 2001-04-30
DE69928524T2 (de) 2006-08-10
ES2155048T1 (es) 2001-05-01
IL139576A0 (en) 2002-02-10
DE1082102T1 (de) 2001-09-06
PL344051A1 (en) 2001-09-24
EP1082102A1 (de) 2001-03-14
KR20010052348A (ko) 2001-06-25
CA2331527C (en) 2010-04-13
US6537576B1 (en) 2003-03-25
AU4405099A (en) 1999-11-29
ZA200006474B (en) 2001-09-04
AU736480B2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
AR030043A1 (es) Sistema de agentes de hidrofobizado, polisiloxano, procedimiento para la obtencion de polisiloxanos, dispersiones acuosas, procedimiento para la obtencion de dispersiones acuosas, procedimiento para el hidrofobizado de sustratos, sustratos hidrofobizados y empleo del sistema de agentes de hidrofobiz
KR910009849A (ko) 기질 처리방법
NO20005724L (no) Biologisk aktiv sammensetning
Patil et al. Sucrose diacrylate: a unique chemically and biologically degradable crosslinker for polymeric hydrogels
TR200200822T2 (tr) Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci
KR910006155A (ko) 유출액이 함유하는 유기물질 및 설페이트를 제거하기 위해 혐기성 발효를 이용하여 유출액을 처리하는 방법
BR0109265A (pt) Processo para a obtenção de polihidroxialcanoatos (pha) ou seus copolìmeros e utilização de agentes de redução
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
CA2048242A1 (en) 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors
Guillory et al. Covalent labeling of the tetrodotoxin receptor in excitable membranes
BRPI0514743A (pt) métodos de isolamento de 1, 3-propanodiol e de 1, 2-propanodiol
EP0331745A4 (en) Ferrocene derivatives, surfactants containing same, and process for producing thin organic film
NO20005725D0 (no) Biologisk aktiv sammensetning
DE19634122A1 (de) Neuartige Bäder zur Erzeugung von Mikrostrukturen
Quastel The mechanism of bacterial action
TW200506531A (en) Photoresist composition for deep uv and process thereof
BR9807726A (pt) Processo para a preparação de um composto
JPS60243165A (ja) 一時的保護被膜及びその製造方法
CA2353529A1 (en) Method for reducing free-radical induced injury
DE69928254D1 (de) Behandlung von zellen
BR0005589A (pt) Processo de reciclo de catalisadores homogêneos em sistemas lìquidos bifásicos contendo polìmero e solventes orgânicos
DE3427888A1 (de) Verfahren zur immobilisierung von biologischem material
GB2404441A (en) Assay methods relating to the action of geminin in the licensing of dna replication complexes in transformed cells
KR910014148A (ko) 흡수 침강형 정수제의 제조방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application